Therapeutic leukocytapheresis for inflammatory bowel disease.
about
Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease.Cytapheresis in patients with severe ulcerative colitis after failure of intravenous corticosteroid: a long-term retrospective cohort study.Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA.Efficacy, safety and cost analyses in ulcerative colitis patients undergoing granulocyte and monocyte adsorption or receiving prednisolone.Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications.Computer-Aided Prediction of Long-Term Prognosis of Patients with Ulcerative Colitis after Cytoapheresis Therapy.Acquisition of antigen-presenting functions by neutrophils isolated from mice with chronic colitis.Granulocytes and monocytes apheresis induces upregulation of TGFβ1 in patients with active ulcerative colitis: A possible involvement of soluble HLA-I.Adsorptive granulocyte/monocyte apheresis for the maintenance of remission in patients with ulcerative colitis: a prospective randomized, double blind, sham-controlled clinical trial.Systemic macrophage depletion inhibits Helicobacter bilis-induced proinflammatory cytokine-mediated typhlocolitis and impairs bacterial colonization dynamics in a BALB/c Rag2-/- mouse model of inflammatory bowel disease.Combination Therapy with Intensive Granulocyte and Monocyte Adsorptive Apheresis plus Adalimumab: Therapeutic Outcomes in 5 Cases with Refractory Crohn's Disease.Granulocytapheresis in the treatment of patients with active ulcerative colitis.Adsorptive Granulocyte and Monocyte Apheresis in the Treatment of Ulcerative Colitis: The First Multicenter Study in China.The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review.Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders.Therapeutic Apheresis in Pregnancy: Three Differential Indications With Positive Maternal and Fetal Outcome.Daily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospective safety and feasibility study.Ulcerative colitis with hepatitis B virus infection treated successfully by granulocyte monocyte apheresis.Granulocyte and Monocyte Adsorption Apheresis for Generalized Pustular Psoriasis: Therapeutic Outcomes in Three Refractory Patients.Relevance of the processed blood volume per granulocyte and monocyte apheresis session to its clinical efficacy in patients with ulcerative colitis.Looking for endoscopic features of cytomegalovirus colitis: a study of 187 patients with active ulcerative colitis, positive and negative for cytomegalovirus.Ulcerative colitis and granulocyte-monocyte-apheresis: safety and efficacy of maintenance therapy during pregnancy.Questionnaire based assessment of patients' acceptability of leukocytapheresis for the treatment of inflammatory bowel disease.Flare up of ulcerative colitis during pregnancy treated by adsorptive granulocyte and monocyte apheresis: therapeutic outcomes in three pregnant patients.Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.Treatment options for children and adolescents with inflammatory bowel disease: is granulomonocytapheresis an effective alternative to drug therapy?Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: Efficacy of a non-drug intervention for patients refractory to pharmacologics.Faecal lactoferrin is a useful biomarker for mucosal healing in patients with ulcerative colitis during granulocyte and monocyte adsorptive apheresis therapy.Granulocytapheresis and plasma exchange for severe alcoholic hepatitis.The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease.Inhibition of CXCL10 release by monomeric C3bi and C4b.
P2860
Q33626027-E704C55A-DBDE-44FA-ADE1-1E2DB5EAD67CQ33855532-94F3EEFA-CBDC-428C-9B63-ED41DC8C4B7AQ34008773-395DA022-BA6E-402C-96DD-B46013C6D67CQ34582547-D3A3BFE2-CCD4-4EE8-B61F-8CD6F370D13BQ34604561-8D80BE4C-260C-499A-B724-69CC5AF6FB65Q34958550-4113B796-F516-4E61-A2D9-F2E74BA0BCF9Q35674635-52299416-03CD-4BEC-BD37-70ECF8761ED2Q35685541-BD292C43-8049-4845-BA63-9468FEAACF10Q35990398-E476AEA5-F9E4-4D69-800D-90E5F4CAE49DQ36385158-BE4EA36D-BAA2-43DA-9B59-8DCB9B8FA954Q36396805-FECED87D-BD4A-42D0-A487-9E893581BFC0Q36551351-407E30A3-58A9-4312-AD8E-ACE57A43E96EQ37345830-10638EA6-8ADC-44F2-9027-797D28C198E7Q37696035-108B97AC-194B-488E-BB35-C2D74A875409Q37809574-E1B49AEC-D55F-4175-818D-ADD59DBAC053Q38243723-FF600746-AAAC-4864-AB00-96202F09AA4AQ38895910-0443CB6C-56F6-45F1-A2D0-E32D66C1B615Q40321418-67061EA1-DB1E-449A-9E52-3EE360405ECEQ40791556-BCDE95D4-456E-4891-B8D2-B2E138EF65A8Q41952126-1C6697BC-12DA-4631-A824-29CCACDB62A3Q44433975-DDFEFC89-6604-4902-9324-A3FF6593E866Q44477713-CCB55ADB-53D1-4C1F-92AD-090857FCDBF6Q45067486-7C9FFF1C-1BF1-4033-B2C4-9C8453893C1FQ46036710-17E76D18-1148-4A3A-B548-51A2E63AA3C1Q46220921-83FBF7C6-2126-4715-B917-EDB67D2DCA9FQ46303987-9D463EF7-463A-446F-877E-A814387459E5Q46821578-7ED54F6D-56ED-4D49-8AD8-7DC4E4211AB8Q47694487-AFC0F11F-3537-4A5E-8B0F-178AAC06172BQ48296840-B51858F8-6114-4550-929A-04D638502BE7Q50944124-AD007B96-B222-451E-BE65-F3A7E55BE0D2Q51424760-65AF47CC-D885-4345-97D7-C37E181CE929Q51765029-29626671-CABC-4760-A842-557DCFBEDCE6Q54336041-C10778EC-1F65-426A-A1FE-D35BD8D7744F
P2860
Therapeutic leukocytapheresis for inflammatory bowel disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Therapeutic leukocytapheresis for inflammatory bowel disease.
@en
type
label
Therapeutic leukocytapheresis for inflammatory bowel disease.
@en
prefLabel
Therapeutic leukocytapheresis for inflammatory bowel disease.
@en
P2093
P1476
Therapeutic leukocytapheresis for inflammatory bowel disease.
@en
P2093
Abbi R Saniabadi
Chikako Shima
Hiroyuki Hanai
Ingvar Bjarnason
Ken Fukunaga
Koji Sawada
Robert Lofberg
P304
P356
10.1016/J.TRANSCI.2007.08.003
P577
2007-10-31T00:00:00Z